Global Autoimmune Disease Diagnostics Market 2021-2026: Rising Disease Awareness Boosts Usage Rates prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Earlier this week, copies of a coroner report stating the cause of death for Garrett Lockhart, aka i o, were passed around social media, listing late stage Hashimoto’s thyroiditis as the cause. Out of respect for the family, we chose not to cover the report, but the family has now released an official statement confirming the autopsy and cause of death.
“This [disease] is unusual in young males and if undiagnosed, can have severe, and some times fatal consequences. These include fatigue, anxiety, depression and cardiac arrhythmias.”
The statement continues, “The coroner has determined that Garrett had a sudden and fatal arrythmia. No toxins were found on extensive and repeated tests. After 5 months of testing, the conclusion is that, while Garrett did suffer from depression and anxiety, he did not take his own life”
Autoimmune Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
The autoimmune disease diagnostics market is expected to register a CAGR of nearly 8. 3% during the forecast period. The rising awareness about autoimmune diseases through programs of research, education, support, and advocacy is a key factor boosting the usage rates of autoimmune disease diagnostics, globally.
May 05, 2021 09:05 ET | Source: ReportLinker ReportLinker Lyon, FRANCE
New York, May 05, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Autoimmune Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - https://www.reportlinker.com/p06067781/?utm source=GNW The United States has the highest incidence of autoimmune diseases, wherein about 50 million patients suffer from autoimmune diseases. According to Arthritis Foundation, in 2017 about 54.4 million a
124 Patient Groups Urge Biden Administration to Improve Prescription Drug Affordability
Advocates Call on HHS Secretary to Ensure Insurance Works for Patients
News provided by
Share this article
HIV+Hepatitis Policy Institute (HIV+Hep) and
American Autoimmune Related Diseases Association (AARDA), in collaboration with 122 other patient and provider organizations, delivered a sign-on letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra that urges HHS and the Biden administration to enact policies and protections that improve prescription drug affordability for the American people. The letter details how recent trends in the healthcare system, including high deductible plans and high cost-sharing, have threatened treatment affordability for patients, which negatively impacts adherence and worsens health outcomes. The patient advocates encourage Secretary Becerra and the Biden administration to:
124 Patient Groups Urge Biden Administration to Improve Prescription Drug Affordability prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.